GREAT AT SMALL THINGS

0

GeneCorner plasmid details

Last data update: 24 January 2024 16:39 CET

Plasmid name: pRcRSVp65 (LMBP 5083)

Add to cart

New search Print data sheet
Price category: Cat. 1 (cf. price list)
Status: GeneCorner core plasmid
GeneCorner sequence: p5083.gb (View with Genome Compiler)
p5083.txt
p5083.pdf
Sequence
analysis results
Genecorner:

-

Cloned DNA: Human nuclear factor κB cDNA (NF-κB); p65 (RELA) subunit
Promoter: Rous sarcoma virus long terminal repeat (RSV-LTR)
Simian virus 40 early promoter (SV40 early)
Escherichia coli lac operon promoter
Ribosome
binding site:
-
Terminator: Bovine growth hormone polyadenylation signal (BGH polyA)
Simian virus 40 polyadenylation signal (SV40 polyA)
Selection marker: Ampicillin (amp)
Neomycin (neo; G418)
Replicon: Escherichia coli plasmid pMB1 origin
Phage f1 origin
Simian virus 40 bidirectional origin (SV40)
Host range: Escherichia coli
Mammalian cells; SV40 permissive cells
Parental clone: pGal4-p65; pRSVp65; pRc/RSV
Further information: The plasmid was constructed by ligating the following three fragments: 1) the 5148 bp NotI (filled in with T4 DNA polymerase)-HindIII fragment of pRc/RSV; 2) the 1006 bp HindIII-BsaI fragment of pRSVp65 (gift from Dr Manfioletti, University of Trieste, Trieste, Italy); 3) the 933 bp AflII (Bst98I)(filled in with T4 DNA polymerase)-BsaI fragment of pGal4-p65.
The plasmid was designed for the expression of the hNF-κB p65 subunit under the control of the RSV-LTR promoter in mammalian cells.
There is uncertainty about the presence of a second enhancer in the SV40 early promoter. The absence of a second enhancer in this promoter may cause bacterial leakage expression of the Tn5 neomycin resistance gene.
This would cause transformed E. coli cells to be resistant to kanamycin, although growth should be reduced compared to growth on medium containing ampicillin.
The nucleotide sequence of this plasmid corresponds with the EMBL Nucleotide Sequence Database accession number LT727080.1.
The nucleotide sequence of pRc/RSV was obtained from Invitrogen (http://www.invitrogen.com; Version A).
The nucleotide sequence of the hNF-κB p65 cDNA corresponds with the EMBL Nucleotide Sequence Database accession number M62399.1. The nucleotide sequence of the 3' UTR of the hNF-κB p65 cDNA was retrieved from the pRc/CMV-p65 sequence file provided by S. Plaisance (Dept of Biomedical Molecular Biology, Ghent University, Belgium).
EMBL Accession number: M62399.1, view at EMBL, GenBank, DDBJ
LT727080.1, view at EMBL, GenBank, DDBJ
Latest sequence update: 18/10/2005
Authenticity test: Restriction enzyme pattern analysed at GeneCorner: BglI/XhoI, Bst98I/HindIII, BstEII/NotI, Csp45I/StuI, EcoRV/NdeI, KpnI and PvuI/SalI.

As compared to the compiled nucleotide sequence, the restriction site analysis pattern revealed that EcoRV only cuts once instead of twice. The EcoRV site at position 615 could not be experimentally confirmed. As the compiled nucleotide sequence has not been adapted accordingly, EcoRV is not indicated as a unique site.
Class: Recombinant plasmid
Type: Plasmid
History of deposit: This plasmid was deposited by Dr L. Vermeulen(1) and Prof. Dr G. Haegeman(1).
(1) Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium
Plasmid reference: Vermeulen et al., EMBO J. 22 (2003), 1313-1324 [PMID: 12628924]
Related plasmid reference: Reber et al., PLoS One. 4 (2009), e4393 [PMID: 19197368] [DOI: 10.1371/journal.pone.0004393]
Restricted distribution: - BCCM MTA
Distributed as: H/P active culture or plasmid DNA
Host for distribution: Escherichia coli K12 MC1061
Host reference: Casadaban et al., J. Mol. Biol. 138 (1980), 179-207 [PMID: 6997493]
Related host reference: Brigé et al., Biochem. J. 394 (2006), 335-344 [PMID: 16293111]
Cultivation medium: LB-Lennox + ampicillin (100 μg/ml)
Cultivation temperature: 37°C
Biosafety level: L1
Cultivation remark: -
Other culture collection numbers: -

Refer in your Materials and Methods:

pRcRSVp65 (LMBP 5083) is available at BCCM/GeneCorner. This plasmid was deposited by Dr L. Vermeulen and Prof. Dr G. Haegeman and was published in Vermeulen et al., 2003.

Note: Up-to-date, validated data are enclosed with the biological material. Nevertheless, these data are a snapshot at a given moment; further updates are always possible.

New search